Trials / Terminated
TerminatedNCT06080438
Effect of Topical Botulinum Toxin Eyedrop on Palpebral Fissure
The Effect of Topical Botulinum Toxin Eyedrop on Palpebral Fissure Height, Ocular Surface and Tearing
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to test if Topical (applied to the surface of the eye) Botulinum Toxin temporarily lowers the upper eyelid and makes the eyelid appear less open and thereby affects the eye surface and decreases reflexive tearing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Botulinum toxin | 15 units of botulinum toxin administered one time to the eye via eye drops |
Timeline
- Start date
- 2022-11-29
- Primary completion
- 2024-07-28
- Completion
- 2024-07-28
- First posted
- 2023-10-12
- Last updated
- 2024-12-05
- Results posted
- 2024-12-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06080438. Inclusion in this directory is not an endorsement.